PreScission Protease is a fusion protein…

The University of Nebraska Medical Center (UNMC), a state agency within the University of Nebraska system, awarded a purchase order to GenScript USA Inc., located in Piscataway, New Jersey, for the procurement of laboratory reagents. The contract, issued September 17, 2026, with a completion date of September 23, 2026, specifies delivery of three units of PreScission Protease (material number Z02799-250), a fusion protein utilized in molecular and biological research applications. The total contract value is $540, calculated at $180 per unit, with delivery to be made free on board (F.O.B.) destination to UNMC General Supply in Omaha, Nebraska.

Performance of this purchase order is located at the University of Nebraska Medical Center in Omaha, Nebraska. Payment terms are Net 30, with all shipments made freight prepaid unless otherwise specified. The purchase order is tax-exempt under exemption number 05-8905401 and is governed by the Standard Terms of Purchase established by the University of Nebraska, unless superseded by a separate agreement between the vendor and the Board of Regents of the University of Nebraska. The contract was posted for public record on September 17, 2026.